0001824299-20-000002.txt : 20200911 0001824299-20-000002.hdr.sgml : 20200911 20200911151408 ACCESSION NUMBER: 0001824299-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200911 DATE AS OF CHANGE: 20200911 EFFECTIVENESS DATE: 20200911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIN-16 Neurexis Therapeutics, LLC CENTRAL INDEX KEY: 0001824299 IRS NUMBER: 844983814 STATE OF INCORPORATION: AR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-375346 FILM NUMBER: 201170765 BUSINESS ADDRESS: STREET 1: 535 W RESEARCH CENTER BLVD STREET 2: SUITE 135 CITY: FAYETTEVILLE STATE: AR ZIP: 72701 BUSINESS PHONE: 4795212592 MAIL ADDRESS: STREET 1: 535 W RESEARCH CENTER BLVD STREET 2: SUITE 135 CITY: FAYETTEVILLE STATE: AR ZIP: 72701 FORMER COMPANY: FORMER CONFORMED NAME: VIN-16 Neurexis Therapeutics DATE OF NAME CHANGE: 20200911 D 1 primary_doc.xml X0708 D LIVE 0001824299 VIN-16 Neurexis Therapeutics, LLC 535 W RESEARCH CENTER BLVD SUITE 135 FAYETTEVILLE AR ARKANSAS 72701 4795212592 ARKANSAS VIN-16 Neurexis Therapeutics Limited Liability Company true 2020 Robert Calvin Goforth 535 W. Research Center Blvd. Suite 135 Fayetteville AR ARKANSAS 72701 Executive Officer Director CEO of Manager Other Decline to Disclose 06b false 2020-08-31 false true false 10000 None None None None N/A N/A Fayetteville AR ARKANSAS 72701 AR ARKANSAS CT CONNECTICUT GA GEORGIA TX TEXAS false 500000 130000 370000 false 9 0 0 0 false VIN-16 Neurexis Therapeutics, LLC Robert Calvin Goforth Robert Calvin Goforth CEO of Manager 2020-09-11